Company Showcase Participants

The listing below shows the participants in the Early or Later Stage Showcase sessions, in date/time order.

Early Stage Showcase - Medtech 1
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    Oxford Endovascular Ltd, Mike Karim, CEO (United Kingdom)
  • 13:40 - 13:50
    SelfDiagnostics OÜ, Marko Lehes, CEO (Estonia)
  • 13:50 - 14:00
    Palpation Diagnostics, Steve Hammer, (United Kingdom)
  • 14:00 - 14:10
    Intelligent RespiLabs , Phi Anh Phan, Founder (United Kingdom)
  • 14:10 - 14:20
    Oxford Cardiomox, Ji Wenming, CEO (United Kingdom)
  • 14:20 - 14:30
    Stent Tek Ltd, Sorin Popa, CEO (United Kingdom)
  • 14:30 - 14:40
    Momentum Bioscience, Sumi Thacker, CEO (United Kingdom)
  • 14:40 - 14:50
    Medherant, Nigel Davis, CEO (United Kingdom)
  • 14:50 - 15:00
    MyCartis, Joris Schuurmans, CEO (Belgium)
  • 15:00 - 15:10
    SIME Diagnostics Ltd, Povl Verder, Founder and CEO (United Kingdom)
  • 15:10 - 15:20
    Unguis Ltd, Charles Potter, CEO (United Kingdom)
  • 15:20 - 15:30
    Biosignatures, Will Dracup, CEO (United Kingdom)

Early Stage Showcase - Platform Technology 1
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    OMass Technologies, Jonathan Hopper, CEO (United Kingdom)
  • 13:40 - 13:50
    TrioxNano, Roy Farfara, CTO (Israel)
  • 13:50 - 14:00
    Sibelius, Peter Leyland, CEO (United Kingdon)
  • 14:00 - 14:10
    Lycotec, Ivan Petyaev, CEO (United Kingdom)
  • 14:10 - 14:20
    Liverpool ChiroChem Ltd, Paul Colbon, Founder and CEO (United Kingdon)
  • 14:20 - 14:30
    Nanogenic Solutions , Jonathan Lane, CEO (United Kingdom)
  • 14:30 - 14:40
    Physiomics plc, James Millen, CEO (United Kingdom)
  • 14:40 - 14:50
    TargetGene Biotechnologies Ltd, Yoel Shiboleth, CEO (Israel)
  • 14:50 - 15:00
    IGEM Therapeutics, Tim Wilson, CEO (United Kingdom)
  • 15:00 - 15:10
    metaLinear Ltd, Paul Ko Ferrigno, CEO (United Kingdom)

Early Stage Showcase - Therapeutics 1
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    Mironid, Neil Wilkie, COO (United Kingdom)
  • 13:40 - 13:50
    Arecor Ltd, Sarah Howell, CEO (United Kingdom)
  • 13:50 - 14:00
    Sareum, Tim Mitchell, CEO (United Kingdom)
  • 14:00 - 14:10
    Oxstem, Michael Stein, CEO (United Kingdom)
  • 14:10 - 14:20
    Amal Therapeutics , Madiha Derouazi , CEO
  • 14:20 - 14:30
    Selvita S.A., Wojciech Czardybon, R&D Consulting Director (Poland)
  • 14:30 - 14:40
    Metys Pharmaceuticals AG, Michael Scherz, Founder & CEO (Switzerland)
  • 14:40 - 14:50
    Avacta Group plc, Alastair Smith, CEO (United Kingdon)
  • 14:50 - 15:00
    Elasmogen Ltd, Caroline Barelle, CEO (United Kingdon)
  • 15:00 - 15:10
    Forendo Pharma Ltd, Maarit Merla, Head of Business Development (Finland)
  • 15:10 - 15:20
    Curileum Discovery Ltd, Jeff Moore, CEO (United Kingdom)
  • 15:20 - 15:30
    Agenus, Jennifer Buell, Vice President, Research and External Affairs (United States )

Early Stage Showcase - Therapeutics 2
Tuesday, 9th May - 13:30 to 15:30
Chaired By:
Companies:

  • 13:30 - 13:40
    apceth Biopharma GmbH, Christine Guenther, CEO/CMO/QP (Germany)
  • 13:40 - 13:50
    Eyevensys, Raffy Kazandjian, CEO (France)
  • 13:50 - 14:00
    Cypralis Ltd, Simon Kerr, CEO (United Kingdom)
  • 14:00 - 14:10
    Auspherix, Neil Miller, CEO (United Kingdom)
  • 14:10 - 14:20
    NeuroVive Pharmaceutical AB, Erik Kinnman, CEO (Sweden)
  • 14:20 - 14:30
    BRAINCURES, Krzysztof Potempa, CEO (United Kingdom)
  • 14:30 - 14:40
    Junction Therapeutics, Clyde Hutchinson, CEO (Ireland)
  • 14:40 - 14:50
    Oxstem, Michael Stein, CEO (United Kingdom)
  • 14:50 - 15:00
    Acousia Therapeutics GmbH, Christoph Antz, CEO (Germany)
  • 15:00 - 15:10
    Aurum Biosciences, Jim McGuire, CEO (United Kingdom)
  • 15:10 - 15:20
    Opticin Therapeutics, Jim Millen, CEO (United Kingdom)
  • 15:20 - 15:30
    Chronos Therapeutics , Huw Jones , CEO (United Kingdon)

Later Stage Showcase - Biotech 1
Tuesday, 9th May - 15:30 to 16:30
Chaired By:
Companies:

  • 15:30 - 15:45
    Mereo BioPharma Group plc, Denise Scots-Knight, CEO (United Kingdom)
  • 15:45 - 16:00
    Rexgenero, Joe Dupere, CEO (United Kingdom)
  • 16:00 - 16:15
    Cell Medica, Gregg Sando, CEO (United Kingdon)

Later Stage Showcase - Pharma 1
Tuesday, 9th May - 15:30 to 16:30
Chaired By:
Companies:

  • 15:30 - 15:45
    NeRRe Therapeutics, Mary Kerr, CEO (United Kingdom)
  • 15:45 - 16:00
    Archer Pharmaceuticals, Michael Mullan, CEO (United States)
  • 16:00 - 16:15
    Debiopharm International SA, Sandya Von Der Weid, Partnering Manager Europe & Asia (CH)
  • 16:15 - 16:30
    Inveni AI, Michael Mulqueen, Business Development, Europe (United States)

Later Stage Showcase - Pharma 2
Tuesday, 9th May - 15:30 to 16:30
Chaired By:
Companies:

  • 15:30 - 15:45
    Addex Therapeutics , Tim Dyer, CEO (Switzerland)
  • 15:45 - 16:00
    Sanifit, Joan Perelló , CEO and Co-Founder (Spain)
  • 16:00 - 16:15
    Galecto Biotech, Hans Schambye, CEO (Denmark)
  • 16:15 - 16:30
    Isansys Lifecare, Keith Errey, CEO (United Kingdom)

Early Stage Showcase - Therapeutics 3
Wednesday, 10th May - 10:10 to 11:10
Chaired By:
Companies:

  • 10:10 - 10:20
    eTheRNA immunotherapies NV, Dirk Reyn, CEO (Belgium)
  • 10:20 - 10:30
    Exscientia, Andrew Hopkins, CEO (United Kingdom)
  • 10:30 - 10:40
    Parkure Ltd, Lysimachos Zografos, CEO (United Kingdom)
  • 10:40 - 10:50
    StemTek Therapeutics, Angel Garcia Martin, CEO (Spain)
  • 15:20 - 15:30
    Novotech, Alek Safarian, Member of the Board (Australia)

Early Stage Showcase - Therapeutics 4
Wednesday, 10th May - 10:10 to 11:10
Chaired By:
Companies:

  • 10:10 - 10:20
    Viramatix Sdn Bhd, Adlan Hercus, Chief Strategy Officer (Malaysia)
  • 10:20 - 10:30
    Phylogica Ltd, Paul Watt, CSO (Australia)
  • 10:30 - 10:40
    Phision Therapeutics/Univ. College Dublin, Alison Reynolds, Assistant Prof. (Ireland)
  • 10:40 - 10:50
    Locate Therapeutics Ltd, Robin Quirk, CEO (United Kingdom)
  • 10:50 - 11:00
    AlzProtect, Philippe Verwaerde, President and CSO (France)
  • 11:00 - 11:10
    Bridge Therapeutics Inc., Greg Sullivan, CSO/CEO (United States)

Early Stage Showcase - Therapeutics 5
Wednesday, 10th May - 10:10 to 11:10
Chaired By:
Companies:

  • 10:10 - 10:20
    CHAIN Biotechnology, Edward Green, Chief Executive (United Kingdom)
  • 10:20 - 10:30
    Empros Pharma AB, Arvid Söderhäll, CEO (Sweden)
  • 10:30 - 10:40
    Immunic Therapeutics, Daniel Vitt, CEO (Germany)
  • 10:40 - 10:50
    NodThera Limited, Alan Watt, CSO (United Kingdom)
  • 10:50 - 11:00
    Oxford Vacmedix UK Limited, William Finch, CEO (United Kingdom)

Contact us

To discuss Company Showcases, Later Stage Showcases and Perfect Pitch opportunities contact:

Mark Hooper, Head of Sales 
Email: Mark.Hooper@obn.org.uk or tel: +44 (0) 1235 420874 or +44 (0) 7795 688604

Jonathan Rohll, Analyst and EU Project Manager
Email:  jonathan.rohll@obn.org.uk or tel: +44 (0)1235 420 877